TMPRSS2 and prostate carcinoma: The metabolomic characteristics of prostate cancer include heightened Fatty Acid Synthase (FAS)-mediated fatty acid metabolism and uptake, particularly in Transmembrane Protease, Serine 2 (TMPRSS2)-Ets variant 1 (ERG) translocation-positive samples.